A study on the effect of single intake of the test food on blood sugar-related biological markers -a placebo-controlled, double-blind, four-period crossover trial- - A study on the effect of single intake of the test food on blood sugar-related biological markers

IMEQRD Co., Ltd0 sites10 target enrollmentOctober 8, 2022

Overview

No summary available.

Registry

who.int

Start Date

October 8, 2022

End Date

November 20, 2021

Last Updated

2 years ago

Study Type

Interventional

Sex

Male

Sponsor

IMEQRD Co., Ltd

•1\. Individuals who currently have been taking any medication drugs or Chinese herbal medicines for medical treatments. (Single dose to be taken only once is approved.) 2\. Individuals who have severe diseases or a history of severe diseases, such as cardiac\-, hepatic\-, kidney\-, and digestive\- diseases. 3\. Individuals who are managed by medical doctors for diet therapy and exercise therapy. 4\. Individuals who have currently been taking commercially available drugs, quasi\-drug products, and foods or supplements with functional claims which affect blood sugar levels. (However, individuals who can discontinue taking these materials during the trial period after obtaining informed consent will be allowed to join the trial.) 5\. Individuals who drink more than 60 g alcohol/day. 6\. Individuals who live irregular life rhythms, such as work in shift, night shift, and marked irregular eating habits. 7\. Individuals who joined other clinical trials from 1 month before obtaining informed consent in this trial, or those who have currently been joined other clinical trials. Also, those who are planning to join other clinical trials between 4 weeks after this trial. 8\. Individuals who can't stop drinking one day before the experimental day. 9\. Individuals who have drug allergies and food allergies. 10\. Individuals who are unsuitable for this trial, that judged by the principal investigator.